FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Massachusetts Special Commission on Pharmacy Compounding Report
June 12, 2013

In response to the tragic events of the multi-state meningitis outbreak Massachusetts Governor Patrick convened the Special Commission to investigate the oversight of compounding pharmacies. The report, which includes recommendations, was released in January 2013. The Florida Board of Pharmacy … Continue reading


DEA Guidelines to Prescription Fraud
June 12, 2013

Pharmacist’s Guide to Prescription Fraud The purpose of this guide is to ensure that controlled substances continue to be available for legitimate medical and scientific purposes while preventing diversion into the illicit market. It is not the intent of this … Continue reading